Relapse Prevention Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Relapse Prevention Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Relapse Prevention Study Today - Breaking & Trending Today

MedinCell: mdc-IRM's Phase 3 Data to Be Presented for the First Time by Teva at Psych Congress 2021 (Oct. 29-Nov. 1, 2021, San Antonio, USA)

Published: October 21, 2021

14 original presentations describing improvements in patient-centered outcomes, symptoms over time, as well as patient and healthcare professional preferences and treatment experiences with mdc-IRM

Source: finanznachrichten.de

Related Topics:

United StatesChristophe DouatMathilde Bohin Louis Victor DelouvrierNicolas MerigeauDavid HeuzHealth Care Professional PreferencesAdministration FrequencyTeva At Psych CongressNetwork MetaAssociation Of OralTeva PharmaceuticalsNew Drug ApplicationPivotal PhasePsych CongressSubcutaneous Risperidone InjectablePatients With SchizophreniaRelapse Prevention StudyLong Acting Subcutaneous Risperidone InjectableDemonstrated Improved Patient Centered OutcomesContinued Symptom ImprovementPatients With Schizophrenia DuringPlacebo Controlled Relapse PreventionPlacebo Controlled Relapse Prevention StudyCardiovascular Related Adverse EventsPatients With Schizophrenia Treated